Prognostic Significance of CD8 T-cell Spatial Biomarkers in ER+ and ER-Breast Cancer
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Tumor Infiltrating Lymphocytes (TILs) have been shown to be prognostic in Triple-Negative Breast Cancer (TNBC), but are rarely considered in other subtypes, particularly estrogen receptor (ER) positive cancers (70-80% of breast cancers), due to lower TIL counts. However, the spatial proximity of lower abundance TILs has not been evaluated in relation to breast cancer prognosis. In this study, multiplex immunofluorescent-stained images were used to identify cell types based on cytokeratin (Ck), CD8, and FoxP3 expression. Using distance-based visual morphometry between epithelial and immune cells, we computed new metrics, proximity and consistency , which capture spatial relationships between Ck+ tumor cells and CD8+ T-cells. Prognostic significance of proximity and consistency were compared to lymphocyte counts using log-rank tests. Worse relapse-free survival (RFS) was observed for both ER+ and ER-breast cancers with low proximity and consistency of CD8+ cells. Among ER negative breast cancers, proximity had the highest RFS hazard ratio (HR 1.84, 95% CI [1.18,2.87]). Among ER positive participants, RFS hazard ratios for proximity and consistency were 2.04 (95% CI [1.39, 2.98]) and 1.82 (95% CI [1.23, 2.69]) respectively. These associations were stronger than those observed for lymphocyte count (HR 1.35, 95% CI [0.92,1.98], log-rank p-value = 0.13). These IF-derived spatial metrics were also associated with established TILs metrics and RNA-based expression-based measures of tumor adaptive immune response. The prognostic significance of proximity in ER+ breast cancer implies that spatial parameters may identify individuals who would benefit from immune therapy; up to 75% of breast cancers experience T-cell proximity suggestive of immune susceptibility.